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Abstract
Different species vary in bone metabolism, especially in modeling and remodel-
ing of the bone. Human-related diseases with severe outcomes on bone, such as 
osteoporosis or osteoarthritis, are often reflected in animal models, which cannot 
adequately mimic the human situation. The pre-clinical investigation of implant 
materials in vivo complicates the search for the ideal animal model, especially when 
combining pathologic bone diseases and implant material. For instance, while 
alterations in trabecular bone architecture are investigated in female osteoporotic 
rats, rodents commonly lack cortical bone remodeling or secondary osteon forma-
tion. Small ruminants are commonly used to study long bone defects or orthopedic 
materials, due to their comparability to humans regarding body weight, bone size, 
and fracture healing. Nevertheless, there are important differences between human 
and ruminant models: plexiform cortical bone, seasonal bone loss, and stronger 
trabecular bone appear in sheep compared to humans. This chapter will summarize 
fundamental differences in bone quality between different animal models used for 
orthopedic and implant material research. Thus, choosing the ideal animal model 
to answer the proposed research question remains the key to guarantee a solid and 
excellent scientific study.
Keywords: animal models, remodeling, orthopedics, pathological bone, biomaterials
1. Introduction
In vivo animal models are frequently used in orthopedic and trauma research. 
Due to ethical issues, researchers are focused to replace animal models by estab-
lishing novel in vitro systems. However, small tissue fragments are often used in 
in vitro systems thereby losing tissue’s architecture at some times. Although it 
is possible to use in vitro organ and tissue cultures that allow preservation and 
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differentiation, the control of dynamic cell properties and simulation of cell 
interactions remain difficult. In orthopedic and trauma research, the major disad-
vantages involve the placing of physiological loading and the cellular and molecular 
orchestration compared to the in vivo system. Hence, animal models are essential 
not only to evaluate pathological bone but also to study tissue response, biocompat-
ibility and mechanical properties, especially when it comes to implant materials [1].
While small animals (mice and rats) are most commonly used due to lower 
costs (e.g., purchase, breeding, and housing), easy handling and the feasibility to 
enlarge the animal number, large animals (sheep and dogs) show several advantages 
including bone size, body weight, and bone quality when compared to humans. 
Murine animal models are commonly used to evaluate pathophysiology and novel 
treatment strategies [2]. For example, mice are highly adaptable to pathological 
conditions by experimental manipulation. Moreover, molecular tools, antibod-
ies, and the well-characterized mouse strains (including knock-out or transgenic 
models) make the use of these animals more advantageous [3, 4]. There has been 
a long debate on whether rodents are appropriate to study osteophysiology due to 
the lack of true skeletal maturity (e.g., lack of Haversian remodeling and closure of 
epiphyseal growth plate) [2]. Larger animals, such as sheep and dogs, show several 
advantages over small models, including their life span and extended phases of skel-
etally matured bone, but seasonal bone loss and plexiform cortical bone especially 
occur in sheep. Thus, there is no animal model that entirely fulfills all requirements 
making it necessary to follow a particular research question and to confirm results 
obtained in research on small animal models in large animals before entering the 
clinics.
In this chapter, we will mainly focus on four animal models including mouse, 
rat, sheep, and dog. Since there are several bone pathologies, which need in vivo 
research models, we will particularly focus on osteoporosis and osteoarthritis as 
one of the major bone pathologies that are also associated with implant and scaffold 
research. Moreover, we will provide an overview about implant research in orthope-
dics and trauma surgery with specialization on bioresorbable implant technology.
2. Bone biology
Animal models are usually chosen by genetic background considerations that 
might influence bone phenotype, thereby assessing bone properties including bone 
mineral density, hardness, biomechanics, and elasticity [1]. Bone quality includes 
several variables such as geometry, architecture, composition (e.g., collagen and 
matrix components), cortical porosity, turnover, and damage and bone mineral 
density. However, bone quantity is classified as mineral mass or bone mineral 
content. In general, there are two major processes involved in bone development 
and maintenance.
2.1 Modeling
Bone modeling in general describes bone formation without prior osteoclastic 
resorption (uncoupled bone formation). This is the case during initial bone growth 
due to embryogenesis, as well as due to sequences in bone fracture healing and 
pathological bone situations, including inflammation or bone tumors. Bone model-
ing results in bone microstructures which are referred to as primary and woven 
bone. Histologically, primary bone can be separated into three types of structurally 
different bone tissues: primary lamellar bone, plexiform or laminar bone, and 
primary osteons. Depending on the vertebrate species, the state of development, 
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but also the site of the skeleton, fulfills different kinds of functions. Primary bone 
is usually build up fast and gets remodeled to secondary bone during maturation. 
Woven bone, on the other hand, is a repair tissue, which builds the callus during 
fracture healing. There is no osseous or cartilage template (anlage) needed to build 
up woven bone. This kind of bone tissue shows a higher degree of mineralization 
and more porosity then secondary bone, but exhibits less mechanical qualities, as 
the embedded collagen-fibers are more or less disorganized. Typically, it also gets 
remodeled to secondary bone during bone maturation, with a few exceptions (e.g. 
alveolar bone and sutures of the cranium) [5, 6].
2.2 Remodeling
Bone is permanently rebuilt throughout the body to assure bone mineral 
homeostasis, to regenerate microfractures, or to adapt the bone to new load. 
Bone-degrading osteoclasts and bone-forming osteoblasts work together in a highly 
concerted procedure. The balance between bone resorption and formation is crucial 
for physiological bone metabolism. If the balance in between resorption and forma-
tion is disturbed, this can result in diverse disease patterns. In osteoporosis, for 
example, more bone is resorbed than is subsequently build; conversely, in osteope-
trosis, more bone is formed than was previously degraded. Bone remodeling takes 
place within microscopical construction sites, the Basic Multicellular Units (BMUs). 
A BMU includes those osteoclasts, osteoblasts, and osteocytes involved in a par-
ticular remodeling event. BMUs in average are about 1–2 mm long, with a diameter 
between 0.2 and 0.4 mm. Cortical bone remodeling results in a secondary osteon 
(Havers’ System), which in the center includes a neuro-vascular channel to provide 
the bone with nutrients and signals. Trabecular remodeling takes place in the 
spongy parts of the bone and results in so called avascular hemi-osteons. Trabecular 
bone is provided with nutrition by blood vessels from the medullary cavity [6–8].
3. How to choose the right animal model depending on bone pathology
In translational research, in vivo animal models are an important tool and 
have to be chosen carefully, when studying pathophysiology of diseases, implant 
materials or treatment options. To investigate diseases, there are several approaches 
including xenograft and genetically engineered models as well as inbred strains. 
However, results obtained from in vivo animal studies differ in their translatability 
to the clinical condition [9]. Generally, there are several other factors which have 
to be taken into account when choosing the animal model, for example, length of 
the experiment, costs for food and housing, experiment type and primary outcome 
measures.
Small animal models, especially mice and rats, exhibit several advantages 
including easy handling, lower costs, and quick experimentation, due to their short 
life span and enhanced metabolism. While small animals serve as ideal models to 
examine pathophysiology and pathogenesis as well as new treatment options, large 
animals, such as sheep and dogs are also often used to study long-term diseases pro-
cesses and treatment options. Therefore, researchers suggest to additionally confirm 
treatment options’ efficiency in large animal models before clinical use [10].
3.1 Rodents
Rodents are well-established in vivo models preferably used in translational 
research of different disciplines as well as in bioactivity and feasibility studies due 
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to their well-defined genetics, biology, and immunology. Accordingly, the repro-
ducibility is quite high. Due to their limited life span, rodents are favorably used for 
age-related bone metabolic and regenerative studies [11, 12]. Bone biology strongly 
depends on gender and age. However, there are also several differences within 
animal strains and after genetic manipulations. For example, fracture healing 
was strongly enhanced in C57BL/6 mice compared to C3H and DBA/2 [13]. Bone 
modeling (growth and reshaping) of the skeleton occurs throughout rodent’s life 
cycle, and the epiphyseal growth plate still remains open throughout adulthood. 
Trabecular bone content is limited in rodents, and Haversian remodeling does not 
occur, whereas cancellous remodeling is established in rodents [14].
3.2 Large animals
Within processes which are related to body size or metabolic characteristics, like 
biomechanics (e.g., fracture fixation) or bone healing efficiency, respectively, the 
animal model (size and anatomy) should be as close to the human situation as pos-
sible [15, 16]. Martini et al. discussed the utilization of animal models in the field of 
orthopedic research from 1970 to 2001. Within the first decade (1990–2001), they 
reported a relative increase of sheep from ~6 to 8–9%, when compared with the two 
decades before. However, in parallel to the increase of sheep models, the relative 
amount of dogs used in orthopedic research decreased for about the same percent-
ages (due to, for example, easier handling, ethical reasons) [17].
To the best of our knowledge, no deeper literature recherché was performed 
since then. Nevertheless, we expect a further increase of sheep being used as an 
animal model for orthopedics and traumatology.
3.2.1 Sheep
The cortical fraction of mature long bones in sheep is reported to exhibit a 
mixture of primary and secondary bone tissue. Plexiform bone appears close to the 
periosteum, while Haversian tissue occurs close to the endost, with a mixture of 
both in the mesosteal zone. Young animals up to 3–4 years in contrast exclusively 
show plexiform bone throughout whole sections of femora. For sheep, significantly 
higher bone densities have been observed compared to human bone. For example, 
the trabecular bone density of sheep femora is about 1.5–2-times higher than the 
density of that in humans. These values, however, are strongly related to the bone 
site where they have been measured and might not be predictive for the trabecular 
bone density of other bone locations, such as vertebrae [18]. Even though there are 
clear differences in bone microstructure, studies reported that sheep exhibit similar 
bone remodeling and turnover when compared to the human situation [19]. Sheep 
might be also an alternative model for studying osteoporosis. However, as there are 
differences in endocrinology and the gastrointestinal tract, it has been suggested to 
investigate the influence of these parameters on seasonal factors, hormones or low 
bone turnover during long days [20].
3.2.2 Dog
Bone composition, density, and quality were investigated in different species 
including chicken, cow, pig, dog, and sheep. On basis of the weight of ash, the 
content of hydroxyproline, extractable protein, and IGF-1, canine bone showed the 
greatest comparability to human bone. When it comes to bone density, dog and pig 
were suggested to closely mimic human bone. However, it was concluded that the 
canine model seems to represent the human situation the best [21]. Kimmel et al. 
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stated that there are similarities in trabecular bone; however, the bone turnover 
might be more difficult to match between human and the canine model, as even the 
same bone types from different sites of the same animal show high variability in 
turnover [22].
In comparison with the typical secondary osteonal microstructure in human 
cortical bone, Wang et al. reported that canine cortical bone rather consists of a 
secondary osteonal core, which is flanked to both sides (periosteal and endosteal) 
by plexiform bone. Plexiform or laminar bone is found predominantly in large and 
fast growing animals, but not in humans after embryogenesis [23].
3.3 Osteoporosis
3.3.1 Clinical significance
The advancing prevalence of post-menopausal osteoporosis is associated with 
increasing age of the population. Osteoporosis is characterized by weakening of the 
bone mass and density consecutively increasing the risk of bone fractures. In 2010, 
3.5 million incident fragility fractures (fractures under osteoporotic conditions) 
were recorded in the European Union, which also increases the economic burden 
associated with high healthcare costs [24]. The strong increase in age is closely 
associated with the increase to suffer not only from a single fracture but also from 
multiple fractures at an advanced age. Worldwide, 1 in 3 women and 1 in 5 men 
over 50 will experience osteoporotic fractures [25, 26]. A quarter of those with hip 
fractures never walk again or even die [27].
Since the 1940s, when Fuller Albright demonstrated that estrogen can reverse 
negative calcium balance in post-menopausal women, there is a remarkable advance 
concerning osteoporotic drugs. However, concerns have been raised when it comes 
to anti-resorptive drugs, such as bisphosphonates, especially about rare side effects 
[28]. Therefore, researchers also focus on enhancing patient’s acceptance and 
compliance with anti-resorptive drugs and in parallel evolving novel drugs without 
long-term side and prolonged anabolic effects.
3.3.2 Osteoporosis-related outcome on bone
Osteoporosis is a skeletal disorder that is generally subdivided into primary and 
secondary osteoporosis, latter describing osteoporosis as a secondary outcome to 
chronic diseases such as Cushing’s syndrome. In contrast, primary osteoporosis 
involves type 1 post-menopausal and type 2 senile osteoporosis. Post-menopausal 
osteoporosis is a multifactorial disease characterized by weakening of the trabecular 
and cortical bone structure (Figure 1). During osteoporosis, loss of bone results 
in decreased total mineralization, leading to reduced tensile bone strength and 
increased risk of fracture. During bone fracture healing, mechanical and biologi-
cal factors are negatively affected by osteoporosis [29]. Under healthy conditions, 
however, cellular and molecular events are carefully orchestrated, thereby produc-
ing a template for regeneration and remodeling of the fracture site, followed by 
bone function restoration, resulting in successful fracture healing [30]. Under 
osteoporotic conditions, reduced numbers and/or reduced activity of osteogenic 
cells including mesenchymal stem cells and osteoblasts, while osteoclast activ-
ity increases. An imbalance of anabolic and catabolic local factors has also been 
linked to osteoporosis [31]. Osteoporotic bone fractures are also associated with 
an impaired bone cell proliferation rate, reduced mechanical stress, and inhib-
ited reactivity to local and systemic stimuli. Impaired vascularization has been 
observed under osteoporotic conditions [29]. However, spontaneously elevated 
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pro-inflammatory cytokine expression such as TNF-α, IL-6, and IL-1 and decreased 
bone forming factors (IGF-1 and TGF-β) are associated with osteoporosis [31].
3.3.3 Animal models for osteoporosis research
Depending on the research aspects of osteoporosis, animal models must be 
carefully chosen: on the one hand, animals are used to investigate anti-resorptive 
drugs (e.g., bisphosphonates), and on the other hand, bone fracture healing and 
novel treatment options (e.g., pharmaceutical, implants, etc.) for bone fractures are 
investigated in vivo [32, 33].
Before choosing the ideal animal model, one must consider different aspects 
in bone physiology. In general, there are different procedures to induce osteopo-
rosis: on the one hand, surgical manipulation by ovariectomy, hypovasectomy, 
orchidectomy, and parathyroidectomy can be performed; on the other hand, diet 
modifications, drugs (e.g., steroids), and immobilization have been used to induce 
osteoporosis. Another possibility is to use aged animals or genetic modification to 
reflect senile osteoporosis. However, there have been several studies that demon-
strated the relevance of rodent models to study post-menopausal (primary osteo-
porosis type 1) and senile osteoporosis (primary osteoporosis type 2). For example, 
the comparability of life time expectancy and closure of the epiphyseal growth 
plate is similar in mice and humans with about 20% in age ratio, and it markedly 
differs in rats with 30% as well as in sheep and dogs with 5–10% [2]. Moreover, the 
genetic uniformity in inbred rodents allows a smaller number of animals compared 
to outbred strains. Another important aspect has to be taken into account when 
conducting bone fracture studies: humans are mainly affected by metaphyseal 
fractures [34].
Mice: The average life span of laboratory mice is between 2 and 3 years, and 
after 8 months, BALB/c and C57BL/L mice show an age-depended decline in 
bone quality and mass (mice lack the Haversian remodeling), but aged animals 
show resorption cavities which are comparable to humans’ Haversian canals [35]. 
The popular laboratory mouse strains, C57BL/L and BALB/c, develop senile 
Figure 1. 
Osteoporosis leads to reduced trabecular bone structure after ovariectomy in female Sprague Dawley rats. 
Micro-computed tomography pictures of the left proximal tibia are presented 4 weeks (left) and 8 weeks 
(right) after ovariectomy (unpublished data).
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osteoporosis-like bone phenotype with decreased bone mass and quality [36, 37]. 
For example, senescence-accelerated mouse (SAM) lines are reasonable models 
to study senile osteoporosis, because the aging phenotype is apparent even after 
6–8 months [38].
Rats: In osteoporosis research, the rat model is most commonly used, especially 
for research on post-menopausal osteoporosis. Considering the bone physiol-
ogy, the transition of modeling to remodeling occurs at 6–9 months of age in the 
proximal metaphysis of the tibia and at 12 months of age in the cortical bone in 
rat. In aged rats, Haversian canals are present, and at the age over 12 months, rats 
represent a good model for senile osteoporosis. However, the major issue with the 
rat model is that ovariectomy induces changes predominantly in the trabecular bone 
(Figure 1), and rats are preferably used to study late stages of bone fracture healing 
[39]. Another advantage when compared to mice is that this model is larger, which 
simplifies surgical procedures and investigation of mechanical properties.
Large animal models: Bone mass is only marginally reduced in dogs following 
ovariectomy and sheep exhibit plexiform bone arrangements in which age-related 
osteopenia does not occur. However, in general, sheep and mini-pig represent the 
most appropriate animal model for both post-menopausal and senile osteoporosis 
(>9 years of age). Nevertheless, extensive costs associated with housing and the 
variability of sheep regarding the aging process is a notable disadvantage for this 
large animal model.
A major disadvantage in aged large animals is that osteoporosis with low bone 
turnover develops only 24 months after hypothalamic-pituitary disconnection. 
Moreover, the typically ovariectomy-induced osteoclast recruitment has not been 
observed with this surgical method [40].
3.4 Osteoarthritis
3.4.1 Clinical significance
The definition of osteoarthritis (OA) depends on the way, how the disease 
was diagnosed including radiography, symptoms, self- or physician-diagnosed. 
Accordingly, the incident and prevalent numbers of OA dramatically vary and are 
also connected to OA with or without symptoms. OA is mainly characterized by 
deteriorated cartilage in joints, thereby resulting in rubbing of the bones leading to 
pain, stiffness, and impaired movement [10]. However, OA predominantly affects 
hands, feet, knees, and spine. OA is an age-depended disease, which is closely 
associated with several risk factors such as less physical activity, obesity, bone 
density, trauma, and gender [41, 42]. Especially, due to the age-related aspect of 
OA, it has been estimated that 15% (130 million) of people over 60 (20% of the 
population estimated by 2050) will exhibit OA-depending symptoms and one-third 
of those will be severely disabled (40 millions) [42]. Diagnostic tools for OA include 
magnetic resonance imaging (MRI), X-ray, and arthroscopy. However, the major 
problem associated with OA is non-modifiable risk factors such as age, gender, and 
genetics.
Hence, the disease must be properly understood to develop novel therapies to 
either stop or reverse the OA progression.
3.4.2 Osteoarthritis: pathogenesis and classification
This pathology leads to cartilage degradation, inflammation of joints, and 
abnormal bone formation [43]. Under healthy conditions, the meniscus, syno-
vial membrane, subchondral bone, and articular cartilage support the joint: the 
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meniscus is composed of type I collagen (also less amount of type II, III, V, and VI 
collagen), proteoglycans, and water and takes over several functions such as load 
bearing in the knee joint [44]; the synovial joints need the articular cartilage to 
move and latter one is composed of type II collagens and proteoglycans; the joint 
and the articular cartilage are nourished by synovial fluid, which is produced by the 
synovial membrane [45]; and the subchondral bone built up from mineralized type 
I cartilages serves to support the joint. The progression of OA can be stimulated 
by different factors; for example, mechanical abrasion tremendously degener-
ates type I and II collagen within the meniscus in the knee and further results 
in a pro-inflammatory situation with increased release of tumor-necrosis factor 
alpha (TNFα), IL-1, IL-4 or IL-13 and enzymes such as matrix-metalloproteinases 
(MMPs) might trigger the OA progress [46]. Due to MMP release, the collagen 
matrix is degraded, leading to articular cartilage degradation and in parallel, and 
the chondrocytes are not even more able to for new cartilage. Hence, abnormal 
remodeling of the subchondral bone, making the calcified cartilage and bone 
interface more acceptable to invades and leading to pain [10]. To date, novel treat-
ment strategies are based on cytokines and the inflammatory situation, such as 
anti-rheumatic drugs [47]. Additionally, other treatment options such as scaffolds 
or lifestyle modifications might play a future role.
Similar to osteoporosis, OA was originally classified in primary and secondary 
OA: while primary OA was to be naturally occurring in either one (localized) or 
more (generalized) joints, secondary OA was associated with risk factors including 
diseases of bone or metabolism, trauma or others. However, there have been several 
debates on the classification of OA, which has been replaced based on recommen-
dations and includes five phenotypes depending on aging, metabolism, genetics, 
trauma, and pain. On the basis of these phenotypes, the following ways to induce 
OA, including advantages and disadvantages have been proposed (Table 1):
3.4.3 Animal models to study osteoarthritis
In order to study the pathophysiology, pathogenesis, and therapeutic effi-
ciency of novel treatment options for OA, there are several in vivo animal models 
[49]. The variability of this disease and the different outcomes for the patients 
make the choice of the ideal in vivo model much more difficult. While pathoge-
netic studies require naturally occurring OA models, molecular biological studies 
make use of genetic models. However, to test therapeutic strategies, surgical mod-
els are preferred (Table 1) [48]. Somebody has also to consider the morphology 
of the lesion and the pathogenesis-involved mediators, especially when testing 
pharmaceuticals [50].
Mice: Murine models are currently used to study primary OA, which is naturally 
occurring and is associated with the time consuming OA development [51]. The 
major disadvantage is huge husbandry costs due to the slow progression (Table 1), 
whereas the translatability to the human situation is given [48]. Genetic models, 
such as the prominent transgenetic model STR/ort with increased oxidative stress 
leading to the naturally development of OA, are particularly useful to investigate 
genes and their interaction with tissue components [52]. Transgenic mice are 
extensively used to both, induce and worsen OA progression, or to protect from 
the disease; to investigate molecular aspects underlying OA, inflammation and 
genetic contribution to OA. Surgical intervention in the knee of mice can be 
performed to induce OA: medial collateral ligament transection with partial medial 
meniscectomy [53] leads to moderate or severe medial cartilage degeneration with 
comparable lesion development in rats. Anterior cruciate ligament (ACL) has 
been described to result in severe lesions. However, the combination of a genetic 
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model with a surgical intervention will be also beneficial to study detrimental 
factors or prophylactic effects of pharmaceuticals during different stages of OA 
[54]. However, chemical intervention using bacterial collagenase by intra-articular 
injection induces OA lesions which vary in severity [55]. Injections must be done 
carefully, otherwise damaging the cruciate ligaments thereby resulting in unwar-
ranted OA lesions.
Rats: OA can only be induced surgically or chemically in rats, since there are 
only rare cases in which minimal focal areas of degenerative tibia can be seen 
[56]. However, OA in rats can be induced via medial meniscal tear or injection of 
iodoacetate, followed by ACL transection. After unilateral medial meniscal tear, 
OA-associated cartilage degeneration rapidly progresses [57] and large lesions can 
be observed. The major disadvantage of this model is the rapid degeneration of the 
cartilage thereby being difficult to observe protective effects. Importantly, toxico-
logic testing is the major advantage of the rat OA model, since efficacy of therapeu-
tic interventions can be obtained easily and in a short duration and rats consistently 
respond to the surgery [50]. The intra-articular single-dose injection of iodoacetic 
acid (25–50 μl of 10 mg/ml) sufficiently kills chondrocytes by inhibition of aerobic 
glycolysis. The outcome on bone is remarkable and forms the basis for the develop-
ment of cartilaginous lesions [58]. ACL transection in mature rats also leads to pro-
gressive changes, especially in the medial joint. In comparison to the meniscal tear 
model, OA progresses much slower after ACL transection and results obtained after 
ACL transection are comparable between rats and dogs. However, due to the slower 
progression, ACL transection is preferred when testing therapeutic interventions. 
Model induction Use Advantage Disadvantage Animal 
model
Naturally 
occurring – no 
intervention 
needed
• Study pathogen-
esis of degenera-
tive OA
• Variable disease 
like in humans
• Long time for dis-
ease development
• Time consuming
• High costs
Mouse, 
sheep, dog
Surgical 
intervention
• Test therapeutic 
efficacy of treat-
ment options
• Examine OA 
lesions and 
stages
• Rapid 
progression
• Reproducibility
• Severe lesions
• Induction of 
traumatic OA
• Due to surgery, 
inappropriate for 
pathogenesis of 
degenerative OA
All
Chemical 
intervention
• Test therapeutic 
efficacy of treat-
ment options
• Examine OA 
lesions and 
stages
• Most rapid 
progression of 
OA
• Less invasive
• Easy 
implementation
• Not correlated 
to any type of 
human OA
All
Genetic 
intervention
• Test genetics 
of OA
• Genomic 
intervention
• Additional carti-
lage abnormalities 
or embryonic 
lethal deletions
• High cost
Mouse
Table has been adapted from [48].
Table 1. 
Methods to induce OA including the use, advantages, and disadvantages as well as most prominent animal 
models used according to the OA induction method.
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Disadvantages of this method are comparable to those in dogs, including variable 
severity of lesions and lesion locations [50].
Sheep: This large animal model is also used to study naturally occurring OA 
(primary OA) with similar advantages compared to mice. For example, sheep have 
been successfully used to study early changes of cartilage degeneration, meniscus 
changes, and treatment options [59].
Dogs: Dogs have been shown to be natural models to study therapeutic inter-
ventions: cranial cruciate ligament transection has been demonstrated to induce 
naturally occurring OA and serves as an interesting model to evaluate structural 
and functional benefits of treatment strategies that will give a better prediction 
for clinics [60]. Moreover, established canine OA models usually undergo ACL 
transection or partial medial meniscectomy. The major disadvantage is that dogs 
need large runs or plenty of exercise, otherwise resulting in mild, variable lesions. 
Additionally, surgical procedures must be carefully performed to avoid traumatic 
lesions. However, if surgical procedures are performed appropriately, OA lesions are 
consistent thereby allowing a relatively small number of animals per group (12–15 
animals per treatment group). Another major advantage is a short screening and 
testing duration of 1 month [50].
Currently, there is no “gold-standardized OA model,” and the most appropri-
ate animal has to be chosen individually, depending on the research question. 
Moreover, extensive work is needed and advantages and disadvantages of the 
models must be clearly outlined in the future.
4. Orthopedic in vivo implant research
In vivo studies are essential to investigate novel implant materials and cannot be 
fully covered by in vitro testing. Preliminary safety tests with new implant materials 
using in vitro models give some information on acute toxicity and cytocompat-
ibility. Nevertheless, some studies use the term of biocompatibility when testing 
implant material in vitro. However, biocompatibility tests need living organisms 
such as animals and humans; therefore, cytocompatibility needs to be correctly 
used when testing in vitro.
In order to test implant safety, adverse tissue reactions as well as corrosion and 
wear resistance need to be investigated to guarantee its long-term application in 
clinics. Hence, in vitro and in vivo tests are essential to evaluate new implant mate-
rials regarding cytocompatibility, biocompatibility, and mechanical stability.
The development of bioresorbable metal implants is one of the major goals in 
orthopedic and trauma surgery. Apparently, the advantages are the unnecessity to 
remove the implant due to material resorption and the associated avoiding of narco-
sis, mandatory for the second removal surgery. Since there is an increasing number 
of patients with metal sensitivity to permanent implants such as titanium (Ti), and 
long-term complications associated with currently available metal implants cannot 
be foreseen to date, there is a high demand to develop novel biocompatible and 
bioresorbable implants with good mechanical properties to stabilize bone fractures.
4.1 Implant design
To test bioresorbable orthopedic implants in animal models, the implant design 
and dimension is of utmost importance. Moreover, the implant number and size 
directly influences the number and species of animals used to test a research 
hypothesis. The most common implant designs used in small animal models such 
as mice and rats are cylindrical-shaped pins [61], whereas screws are the commonly 
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used designs in large animal models such as sheep [62] (Figure 2). However, there 
are much more designs that are less commonly used such as plates and discs. More 
importantly, the size of the implant must be adjusted to the size of the animal which 
is comparable to common implant sizes in humans. In small animal models, cylin-
drical rods are used with a simple geometry that makes it easier to analyze implant 
degradation and behavior. However, these rods have to exactly fit (“press-fit”), 
otherwise the implants will become unstable and will be lost during investigation. 
Screws are more reliable when it comes to comparison with humans, since screws 
are commonly used to stabilize fractures or fix plates in humans [63]. However, the 
geometry is more complicated which makes the analysis more difficult.
Dimensions of implants differ according to the sizes of the animals. For exam-
ple, the most appropriate dimension for cylindrical implants in rabbits is 6 mm 
in length and 2 mm in diameter, whereas the ideal dimension for large animals 
including goat, dog, and rabbit is 12 mm in length and 4 mm in diameter, accord-
ing to ISO guidelines. Proper controls have to be chosen to investigate new implant 
material. According to ISO standards, it is recommended to use currently certified 
materials, which are already used in clinics, as a control [64]. In order to properly 
examine implant material, primary outcomes have to be specified: to test mechani-
cal properties, bone tissue with implants are harvested and undergo pull-out/
push-out tests (cylindrical implants) and torque removal tests (screws) (Figure 2). 
This test usually demonstrates proper integration of the implant in bone [1]. In case 
of resorbable biomaterials, degradation behavior and bone in-growth are the major 
primary outcomes besides mechanical properties. Real-time imaging techniques, 
such as in vivo micro-computed tomography (μCT) in small animals and clinical CT 
in large animals are used to observe material changes (degradation, bone in-growth, 
etc.) over the entire study duration. After reconstruction, 3-dimensional (3D) 
images can be reconstructed, and implant volume loss and bone formation can be 
calculated [61].
Other studies aim to investigate effects of implant surface modifications on 
bone formation and bone-implant interaction. To obtain accurate results, surface 
characteristics including chemical composition and surface topography must be 
determined. Therefore, visual observation (scanning electron microscopy, μCT) 
and numerical analysis (energy dispersive X-ray microscopy, profilometry) must be 
performed [65].
4.2 Implant material
Conventional alloys currently used in the treatment of fractures include Ti and 
stainless steel, which are more rigid with desirable advantages including biocompat-
ibility, good resistance to material corrosion, and most importantly, these alloys 
do not show severe toxic effects on various immune cells and can bear weight soon 
Figure 2. 
Screws (left image) and cylindrical pins (right image) are often used in orthopedic and trauma research.
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after implantation. However, Ti and stainless steel implants have a higher e-modu-
lus (Ti: e-modulus 100–124 GPa; steel: e-modulus 200 GPa) than bone (e-modulus 
6–24 GPa). Moreover, permanent implants can cause “stress-shielding” leading to 
loss of bone under the plate or between bone and implant, thereby increasing the 
risk of refractures, designated as peri-prosthetic or peri-implant fractures [29, 31]. 
Moreover, the FDA has already described possible metallic sensitivity or allergic 
reactions linked to Ti-based alloys, such as Ti-6Al-4V [66], and studies using vana-
dium have also shown adverse effects [67]. However, resorbable materials exhibit 
functional properties by supporting bone formation and in-growth on a molecular 
level. To date there are only few resorbable materials used in cardiac, dental and 
neuro-surgery and some not weight-bearing application in orthopedic surgery, 
but adequate materials for orthopedic and trauma surgeries need good mechanical 
properties. Therefore, the main focus in biomaterial research is to evolve materials 
and tools to develop the optimal implant for the respective bone condition under 
the necessity to bear weight.
4.2.1 Polymers
Poly-L-lactic acid (PLLA) and poly-lactic-co-glycolic acid (PLGA) are the most 
commonly used polymers considered for their use as osteosynthesis and bone grafts 
[68]. Disadvantages of polymers include poor mechanical properties (low strength 
and stiffness, high brittleness) and osteoconductivity. Degradation behavior 
depends on monomers and can be very slow thereby increasing the risk of adverse 
effects such as sclerotic areas in bone and fibrous encapsulation [69].
Alternatively, polyhydroxybutyrate (PHB) can serve as a polymeric implant 
material, which is produced by microorganisms, especially bacteria. However, PHB 
can induce toxicological effects. However, these effects have been reduced dramati-
cally, raising the potential for its application in clinics. Nevertheless, functional 
properties (i.e., osteoinductivity or osteoconductivity) of polymeric implant mate-
rial have not been discovered yet.
4.2.2 Ceramics
Ceramics are synthetic bone replacement materials with good biocompat-
ibility and osteoconductivity, thereby showing good osseointegrative and non-
immunogenic effects. Composed of hydroxyapatite (HA), or alpha (α)- and beta 
(β)-tricalcium phosphates (TCP), ceramics exhibit poor mechanical properties 
including low yield strength and high brittleness, which make them unattractive for 
their application in load-bearing regions.
4.2.3 Bioresorbable metals
In comparison to polymers and ceramics, iron (Fe), magnesium (Mg), and zinc 
(Zn) are more stable, tensile, and load-bearing, respectively. To process Fe-based 
alloys, the low melting point of Fe constitutes an interesting property. However, 
Hofstetter et al. demonstrated that limited access to oxygen was associated with 
slow degradation rates [70]. Metal implants based on Zn display several disad-
vantages including low rigidity and deformability, as well as corrosion inhibition. 
Therefore, Zn is likely more suited as an alloying element in combination with 
other materials. Finally, Mg-based alloys exhibit several advantages including good 
biocompatibility, resorbability, and favorable biomechanical properties. Moreover, 
some studies have demonstrated Mg’s associated functional properties, especially 
its ability to support bone fracture healing [33]. For example, recent studies using 
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26 Mg isotope pins in a rat model demonstrated high Mg content in the bone-
implant interface [71]. Good bone in-growth and a tight interface between bone 
and implant were observed. Additionally, drilled hole bone fractures showed full 
recovery after complete degradation of Mg implants. The serum concentration 
of Mg indicated a high tolerance of increased Mg levels which was controlled by 
urine excretion. Bone formation has been observed after implantation of XHP-Mg-
0.45Zn-0.45Ca implants in young, growing small and large animal models [61].
5. Conclusion
Here, we summarized fundamental differences in small and large animal models 
concerning bone quality, composition as well as their individual advantages and 
disadvantages. Focusing on two major complications in orthopedics and traumatol-
ogy, we wanted to underline the merits of an animal model by supporting with 
scientific results obtained from our intensive literature recherché. Implant research 
is a hot topic in orthopedics and trauma surgery. Based on our expertise, we wanted 
to give insights into implant technology, materials, and designs. Currently, perma-
nent implants are the state-of-the-art material used to stabilize bone fractures in 
orthopedics and trauma surgery. However, to develop the ideal implant for a certain 
bone condition (e.g., osteoporosis and osteoarthritis), the underlying disease and 
the detrimental outcome on bone (e.g., bone mass, fracture risk, and bone density) 
have to be taken into account when choosing the implant material (e.g., Ti-, Mg-, 
Fe-based implants), design (e.g., pin, screw, plate, and scaffold), material proper-
ties (e.g., tensile strength, non- or bio-resorbable), and implantation site (e.g., 
knee, femur, and tibia).
Hence, it is of utmost importance to choose the most appropriate animal model 
according to the research question and warranted primary outcome measures.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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